European Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Hospitals by Country

The 2024 data shows pronounced variation in per capita healthcare expenditure on pharmaceuticals and medical non-durable goods across Europe. Malta leads with the highest expenditure at 224.03 euros per capita, followed by Switzerland and France. Year-on-year changes indicate substantial growth in Malta (17.03%), Switzerland (8.22%), and Lithuania (22.86%), while declines are observed in the Netherlands (-9.47%) and Portugal (-6.96%). Over the last two years, the expenditure has generally increased, with varied trends among countries, reflecting differing healthcare priorities and economic conditions.

Future trends may include:

  • Possible increase in digital health adoption influencing spending patterns.
  • Shifting demographics and aging populations impacting pharmaceutical demands.
  • Potential policy changes in healthcare expenditure as European countries navigate economic challenges and healthcare innovations.

Top countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Hospitals by Country

# 10 Countries Euros Per Capita Last Year YoY 5-years CAGR
1 1 Malta 224.03 2023 +8.87% +17.03% View data
2 2 Switzerland 160.76 2023 +5.68% +8.22% View data
3 3 France 116.96 2023 +4.84% +5.66% View data
4 4 Luxembourg 107.6 2023 +5.6% +7.1% View data
5 5 Italy 88.27 2023 +1.65% +3.13% View data
6 6 Belgium 69.99 2023 +2.37% +8.24% View data
7 7 Cyprus 44.5 2023 +12.83% -0.99% View data
8 8 Czech Republic 33.25 2023 +2.66% +0.26% View data
9 9 Ireland 12.21 2023 +14.11% +4.16% View data
10 10 Latvia 6.08 2023 +3.93% +7.22% View data

Top Countries about Healthcare